Active · per the CBE, 30 September 2026

Dr. Julie Dobbeleir, Plastische Heelkunde

BE0691569220

Rechtspersoon Private limited company 2 establishments

Dr. Julie Dobbeleir, Plastische Heelkunde is a specialist medical practice in Buggenhout. Private Limited, started on 28 February 2018, 2 establishments.

Beekstraat 13, 9255 Buggenhout

Behind the company: Julie Dobbeleir.

Active for

8 year, 7 months

Financials

Financial year 2025

Dr. Julie Dobbeleir, Plastische Heelkunde from Buggenhout, company number BE0691569220, closed financial year 2025 with a result of € 271,884 after tax. For that financial year Dr. Julie Dobbeleir, Plastische Heelkunde recorded a gross margin of € 410,813 and equity of € 888,566. Compared with financial year 2024, the result moved from € 190,202 to € 271,884. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2026.

What it is worth Growing

€ 888,566

▲ 24% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 271,884

▲ 43% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 146,352

▼ 69% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 101,300 paid out

37 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 26,475

▼ 15% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,128

▼ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 20 years to go

€ 241,452

▼ 5% vs 2024

€ 12,236 is repaid this year. At this pace the long-term loan is gone in ≈ 20 years.

Owed to suppliers

€ 24,285

▲ 264% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 28,288

▼ 36% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 363,307 € 361,291 € 338,244 € 410,813 ▲ 21%
Profit after taxes € 210,336 € 216,031 € 190,202 € 271,884 ▲ 43%
Equity € 311,748 € 527,779 € 717,981 € 888,566 ▲ 24%
Total debts € 359,077 € 300,467 € 305,276 € 294,026 ▼ 4%
Cash € 309,105 € 440,936 € 464,958 € 146,352 ▼ 69%
Land & buildings € 212,557 € 200,617 € 188,678 € 176,739 ▼ 6%
Retained profit € 311,648 € 527,679 € 717,881 € 888,466 ▲ 24%
Dividend € 0 € 0 € 0 € 101,300
Bank debt € 282,838 € 268,020 € 254,114 € 241,452 ▼ 5%
Balance sheet total € 670,824 € 828,246 € 1,023,257 € 1,182,591 ▲ 16%

Key figures of Dr. Julie Dobbeleir, Plastische Heelkunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Julie Dobbeleir, Plastische Heelkunde?

What happened at Dr. Julie Dobbeleir, Plastische Heelkunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 271,884 (▲ 43% vs 2024). filed late Source: NBB ↗
  • New establishment in Dendermonde. KBO
  • New establishment in Buggenhout. KBO
  • Start of the company according to the CBE. KBO

In short

From € 210,336 profit in 2022 to € 271,884 profit in 2025.

Paid € 329,485 in corporate taxes since 2022.

Best year ever: 2025, with € 271,884 profit.

Paid out € 101,300 in dividends to the owners in total.

Management

Julie Dobbeleir
Dr. Julie Dobbeleir, Plastische Heelkunde

Behind Dr. Julie Dobbeleir, Plastische Heelkunde is Julie Dobbeleir.

See the full network in the app

Directors

According to the 2025 annual accounts

Julie Dobbeleir

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Beekstraat 13

9255 Buggenhout

2.320.340.958

Noordlaan (DEN) 160 box 0.2

9200 Dendermonde

Active since 4 October 2021

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0691.569.220
VAT number
BE 0691.569.220
Registered office
Beekstraat 13, 9255 Buggenhout
Names & denominations
Dr. Julie Dobbeleir, Plastische Heelkunde
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
28 February 2018
Peppol
Active · Active since 18 Jun 2025
Activities · NACE

Activiteiten van medisch specialisten

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

Frequently asked questions

What does Dr. Julie Dobbeleir, Plastische Heelkunde do?
Dr. Julie Dobbeleir, Plastische Heelkunde is a specialist medical practice in Buggenhout. Private Limited, started on 28 February 2018, 2 establishments.
What is the address of Dr. Julie Dobbeleir, Plastische Heelkunde?
The registered office of Dr. Julie Dobbeleir, Plastische Heelkunde is located at Beekstraat 13, 9255 Buggenhout.
Is Dr. Julie Dobbeleir, Plastische Heelkunde still active?
Yes. According to the CBE (30 September 2026) Dr. Julie Dobbeleir, Plastische Heelkunde is active, legal situation “Normale toestand”, started on 28 February 2018.
Is Dr. Julie Dobbeleir, Plastische Heelkunde registered on Peppol?
Yes, Dr. Julie Dobbeleir, Plastische Heelkunde is registered on the Peppol network with ID 0208:0691569220.
What is the enterprise number of Dr. Julie Dobbeleir, Plastische Heelkunde?
The enterprise number of Dr. Julie Dobbeleir, Plastische Heelkunde is BE0691569220.
When was Dr. Julie Dobbeleir, Plastische Heelkunde founded?
Dr. Julie Dobbeleir, Plastische Heelkunde was founded on 28 February 2018.